Literature DB >> 15681786

Intestinal myofibroblasts and immune tolerance.

J I Saada1, C A Barrera, V E Reyes, P A Adegboyega, G Suarez, R A Tamerisa, K F Pang, D A Bland, R C Mifflin, J F DI Mari, D W Powell.   

Abstract

Stromal cells, such as myofibroblasts and fibroblasts, represent a significant fraction of MHC class II-positive cells in the normal human colonic lamina propria, suggesting they may play an important role in CD4(+) T cell regulation in a tolerogenic environment. The aim of this study was to examine whether human colonic myofibroblasts (CMFs) phenotypically and functionally resemble conventional antigen-presenting cells (APCs). Our results support the hypothesis that intestinal myofibroblasts are a novel, nonprofessional APC phenotype important in modulating mucosal T cell responses. Given their strategic location, we propose that intestinal myofibroblasts play a critical role in mediating tolerance to luminal antigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15681786     DOI: 10.1196/annals.1309.023

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

Review 1.  Inflammatory bowel disease: Moving toward a stem cell-based therapy.

Authors:  Giacomo Lanzoni; Giulia Roda; Andrea Belluzzi; Enrico Roda; Gian Paolo Bagnara
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

2.  TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.

Authors:  Ellen J Beswick; Jameel R Johnson; Jamal I Saada; Martin Humen; Jenifer House; Sara Dann; Suimin Qiu; Allan R Brasier; Don W Powell; Victor E Reyes; Irina V Pinchuk
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

Review 3.  Stem cells as potential therapeutic targets for inflammatory bowel disease.

Authors:  Udai P Singh; Narendra P Singh; Balwan Singh; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti; Shree Ram Singh
Journal:  Front Biosci (Schol Ed)       Date:  2010-06-01

4.  Neonatal colonisation expands a specific intestinal antigen-presenting cell subset prior to CD4 T-cell expansion, without altering T-cell repertoire.

Authors:  Charlotte F Inman; Georgina M Laycock; Louisa Mitchard; Ross Harley; James Warwick; Rachel Burt; Pauline M van Diemen; Mark Stevens; Mick Bailey
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

5.  CD90(+) Stromal Cells are Non-Professional Innate Immune Effectors of the Human Colonic Mucosa.

Authors:  Benjamin M J Owens; Tessa A M Steevels; Michael Dudek; David Walcott; Mei-Yi Sun; Alice Mayer; Philip Allan; Alison Simmons
Journal:  Front Immunol       Date:  2013-09-30       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.